Assessment of Sensory Block During Labour Epidural Analgesia in Patients Experiencing Pain During First Stage of Labour.

Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05881395
Collaborator
(none)
30
1
6
5

Study Details

Study Description

Brief Summary

Epidural analgesia is the gold standard for pain control during labour and an essential component of delivering effective and safe epidural analgesia is the assessment of the epidural sensory block. There is significant literature on the assessment of sensory block during spinal anesthesia for cesarean section but limited studies exploring the assessment of sensory blockade in labour analgesia.

Prior studies have documented two thresholds of sensory block to both ice and pinprick: one defined as the lower sensory block level (LSBL) where the patient is able to notice a cold or sharp sensation but perceives that is not as sharp or cold as a control area and the other the upper sensory block level (USBL) where the patient perceives the cold or sharp sensation is at the same temperature or sharpness as the control area.

The goal of this study is to contribute to the standardization of the assessment of sensory block levels during labour epidural analgesia by studying patients with labour epidurals who are experiencing pain and determining the LSBL and USBL and how these change as the patients become comfortable following the administration of manual epidural top ups.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The pain pathways involved in the process of labour and delivery have been well established. Nociceptive stimuli during first stage of labour are transmitted via the T10 to L1 posterior nerve root ganglia, while the nociceptive stimuli during second stage of labour are transmitted via the L1 and S2 to S4 (pudendal nerve) posterior nerve root ganglia. Although these pain pathways are well established, there is no information in the literature as to what level or depth of sensory block, assessed by current clinical practices, is required for effective labour analgesia. This information is critical for planning and safety of epidural analgesia during labour.

    The investigators hypothesize that the LSBL to either cold or pinprick would be below dermatome T10 in patients receiving labour epidural analgesia during first stage of labour and who are experiencing pain. The investigators also hypothesize that upon receiving a top-up and re-establishment of effective analgesia, (a) the LSBL would be at or above dermatome T10 or (b) USBL would increase to T10 or above T10 if USBL was below T10 before receiving a top-up.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Assessment of Sensory Block During Labour Epidural Analgesia: a Prospective Cohort Study to Investigate the Upper and Lower Sensory Block Levels (USBL and LSBL) to Ice and Pinprick in Patients Experiencing Pain During First Stage of Labour.
    Anticipated Study Start Date :
    Jun 1, 2023
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Women with epidural analgesia experiencing pain during labor

    Patients reporting pain will have their sensory block checked using ice and pinprick tests, prior to, and following and epidural top-up.

    Outcome Measures

    Primary Outcome Measures

    1. Lower sensory block level to ice when the patient is experiencing pain [5 minutes]

      The lower sensory block level to ice, defined as the dermatome at which there is a complete loss of cold perception. This will be checked when the patient is experiencing pain and requesting manual administration of an epidural bolus.

    2. Upper sensory block level to ice when the patient is experiencing pain [5 minutes]

      The upper sensory block level to ice is defined as the dermatome at which there is an altered cold perception without complete sensitivity loss.This will be checked when the patient is experiencing pain and requesting manual administration of an epidural bolus.

    3. Lower sensory block level to pinprick when the patient is experiencing pain [5 minutes]

      The lower sensory block level to pinprick, defined as the dermatome at which there is a complete loss of sharp sensation. This will be checked when the patient is experiencing pain and requesting manual administration of an epidural bolus.

    4. Upper sensory block level to pinprick when the patient is experiencing pain [5 minutes]

      The upper sensory block level to pinprick is defined as the dermatome at which there is an altered sharp sensation without complete sensitivity loss. This will be checked when the patient is experiencing pain and requesting manual administration of an epidural bolus.

    Secondary Outcome Measures

    1. Verbal Numeric Rating Score (VNRS) at the time of request of assessment by anesthesiologist [5 minutes]

      The patient will be asked to report their VNRS (0-10), where 0 is no pain and 10 is the worst pain imaginable

    2. Verbal Numeric Rating Score (VNRS) at 10 minutes after each epidural top-up administered. [10 minutes]

      The patient will be asked to report their VNRS (0-10), where 0 is no pain and 10 is the worst pain imaginable, 10 minutes after epidural top-ups are administered.

    3. Lower sensory block level to ice following epidural top-up [5 minutes]

      The lower sensory block level to ice, defined as the dermatome at which there is a complete loss of cold perception. This will be checked 10 minutes following each top-up or when the patient's pain is reported as 0 or 1.

    4. Upper sensory block level to ice following epidural top-up [5 minutes]

      The upper sensory block level to ice is defined as the dermatome at which there is an altered cold perception without complete sensitivity loss. This will be checked 10 minutes following each top-up or when the patient's pain is reported as 0 or 1.

    5. Lower sensory block level to pinprick following epidural top-up [5 minutes]

      The lower sensory block level to pinprick, defined as the dermatome at which there is a complete loss of sharp sensation. This will be checked 10 minutes following each top-up or when the patient's pain is reported as 0 or 1.

    6. Upper sensory block level to pinprick following epidural top-up [5 minutes]

      The upper sensory block level to pinprick is defined as the dermatome at which there is an altered sharp sensation without complete sensitivity loss. This will be checked 10 minutes following each top-up or when the patient's pain is reported as 0 or 1.

    7. Motor block score using Bromage score at the time of request of assessment by anesthesiologist [5 minutes]

      Motor block will be assessed with the Bromage score: 0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex knees; 2 = unable to flex knees, but able to flex ankle; 3 = unable to flex ankle. This will be checked when the patient is experiencing pain and requesting manual administration of an epidural bolus.

    8. Motor block score using Bromage score following epidural top-up [5 minutes]

      Motor block will be assessed with the Bromage score: 0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex knees; 2 = unable to flex knees, but able to flex ankle; 3 = unable to flex ankle. This will be checked 10 minutes following each top-up or when the patient's pain is reported as 0 or 1.

    9. Number of epidural top-ups required [20 minutes]

      The number of epidural top-ups documented by the anesthesiologist that were required to achieve VNRS of 0 or 1.

    10. Type of pain: questionnaire [20 minutes]

      Patients will be asked to describe their pain as: sharp/dull/pressure.

    11. Location of pain: questionnaire [20 minutes]

      Patients will be asked to describe the location of their pain as: abdomen/back/perineum

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Inclusion Criteria:
    • ASA (American Society of Anesthesiologists) Physical Status Classification II or III

    • Patients admitted to labour and delivery unit at Mount Sinai Hospital in their first stage of labour

    • Patients who have a labour epidural that has been initiated as an epidural, CSE (combined spinal epidural) or a dural puncture epidural (DPE).

    • Patients who are experiencing pain, defined as Visual Numerical Rating Score of more than 1/10, despite our institution's standard epidural Programmed Intermittent Epidural Bolus maintenance regimen and request a manual epidural top-up for the first time

    • Have capacity to consent to the study

    Exclusion Criteria:
    • Patients with a language barrier that may interfere with accurate response to sensory block assessment

    • Patients with medical conditions that would compromise sensitivity to cold or pinprick assessments

    • patients who sustained unintentional dural puncture, those requiring change in our standard epidural maintenance regimen or those who have had a failed epidural requiring replacement.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mount Sinai Hospital Toronto Ontario Canada M5G1X5

    Sponsors and Collaborators

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    Investigators

    • Principal Investigator: Jose Carvalho, MD, MOUNT SINAI HOSPITAL

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    ClinicalTrials.gov Identifier:
    NCT05881395
    Other Study ID Numbers:
    • 23-01
    First Posted:
    May 31, 2023
    Last Update Posted:
    Jun 6, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 6, 2023